Stevens Capital Management LP Lowers Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Stevens Capital Management LP trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 16.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 830 shares of the biotechnology company’s stock after selling 169 shares during the period. Stevens Capital Management LP’s holdings in Axon Enterprise were worth $493,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Geode Capital Management LLC boosted its holdings in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after acquiring an additional 35,320 shares during the period. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after acquiring an additional 9,090 shares during the period. Groupama Asset Managment purchased a new position in Axon Enterprise during the 3rd quarter valued at about $200,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Axon Enterprise by 4.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 449,507 shares of the biotechnology company’s stock valued at $267,151,000 after acquiring an additional 19,818 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of analyst reports. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Robert W. Baird increased their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Trading Up 0.3 %

NASDAQ:AXON opened at $560.00 on Monday. The stock’s 50 day moving average price is $591.90 and its 200 day moving average price is $543.57. The company has a market capitalization of $42.91 billion, a PE ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.